This is a survey study being conducted to describe how subjects with Hidradenitis suppurativa (HS) respond to treatment with gentian violet. The study will rely primarily on qualitative survey responses and quantitative changes in skin appearance.
Hidradenitis suppurativa (HS) is a chronic disease of the folliculopilosebaceous unit, often found in intertriginous areas of the body. The pain and impairment of HS leads patients to report a decreased quality of life, even in comparison to other debilitating cutaneous disease states. Pharmalogic management of HS can vary from topical antibiotics or intralesional corticosteroids for mild cases to immunosuppressants and biologic agents in refractory cases. Gentian violet is a topical antiseptic used to treat many cutaneous yeast infections. It also has a role in improving wound healing in sites of active ulceration. It is our hypothesis that gentian violet will help minimize skin trauma in sites of active HS to promote improved wound healing and quality of life.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Gentian violet is a topical antiseptic used to treat many cutaneous yeast infections. It also has a role in improving wound healing in sites of active ulceration.
Wake Forest School of Medicine
Winston-Salem, North Carolina, United States
Skin's Redness
Subjects rate site redness on a scale from 1 (no redness) to 5 (severe redness)
Time frame: baseline pre-treatment
Skin's Redness
Subjects rate skin redness at treatment site on a scale from 1 (no redness) to 5 (severe redness)
Time frame: 1 month post-treatment
Skin's Drainage
Subjects rate skin drainage at treatment site on a scale from 1 (no drainage) to 5 (severe drainage)
Time frame: baseline pre-treatment
Skin's Drainage
Subjects rate skin drainage at treatment site on a scale from 1 (no drainage) to 5 (severe drainage)
Time frame: 1 month post-treatment
Skin's Pain
Subjects rate skin pain at treatment site on a scale from 1 (no pain) to 5 (severe pain)
Time frame: baseline pre-treatment
Skin's Pain
Subjects rate skin pain at treatment site on a scale from 1 (no pain) to 5 (severe pain)
Time frame: 1 month post-treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.